WallStreetZenWallStreetZen

NASDAQ: MGNX
Macrogenics Inc Stock Ownership - Who owns Macrogenics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Macrogenics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Thomas SpitznagelSr VP Technical Ops2026-02-155,520$1.71
$9.44kSell
Ezio BonviniSr VP Research CSO2026-02-156,433$1.71
$11.00kSell
James KarrelsSVP and CFO2026-02-155,790$1.71
$9.90kSell
Jeffrey Stuart PetersSenior VP GC and Secretary2026-02-155,147$1.71
$8.80kSell
Eric Blasius RisserPresident and CEO2026-02-156,433$1.71
$11.00kSell
Beth Ann SmithVP Controller Treasurer2026-02-15423$1.71
$723.33Sell
James KarrelsSVP and CFO2026-02-083,860$1.81
$6.99kSell
Jeffrey Stuart PetersSenior VP GC and Secretary2026-02-083,474$1.81
$6.29kSell
Eric Blasius RisserPresident and CEO2026-02-084,311$1.81
$7.80kSell
Thomas SpitznagelSr VP Technical Ops2026-02-083,186$1.81
$5.77kSell

1 of 2

MGNX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MGNX insiders and whales buy or sell their stock.

MGNX Shareholders

What type of owners hold Macrogenics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Target N. V. Biotech15.62%9,929,963$42.20MInsider
Vanguard Capital Management LLC4.18%2,653,853$11.28MInstitution
Tpg Group Holdings Sbs Advisors Inc3.47%2,208,762$9.39MInsider
Scott Koenig3.41%2,165,915$9.21MInsider
Alta Biopharma Partners III LP3.17%2,013,509$8.56MInsider
Interwest Partners VIII LP3.00%1,908,716$8.11MInsider
Edward Hurwitz2.75%1,749,070$7.43MInsider
Arnold L. Oronsky2.69%1,708,716$7.26MInsider
Wasatch Advisors LP2.45%1,559,701$6.63MInstitution
Kenneth Galbraith2.07%1,317,049$5.60MInsider

1 of 3

MGNX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MGNX14.87%37.83%Net Buying
AVXL11.88%4.79%Net Buying
ALXO4.30%10.89%Net BuyingNet Selling
CGEN3.84%0.32%Net BuyingNet Buying
SABS6.20%67.81%Net Buying
View Top Biotech Stocks

Macrogenics Stock Ownership FAQ

Who owns Macrogenics?

Macrogenics (NASDAQ: MGNX) is owned by 14.87% institutional shareholders, 37.83% Macrogenics insiders, and 47.31% retail investors. Target N. V. Biotech is the largest individual Macrogenics shareholder, owning 9.93M shares representing 15.62% of the company. Target N. V. Biotech's Macrogenics shares are currently valued at $42.20M.

If you're new to stock investing, here's how to buy Macrogenics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.